Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic review.

Eektimmerman F, Swen JJ, Madhar MB, Allaart CF, Guchelaar HJ.

Pharmacogenomics J. 2019 Oct 17. doi: 10.1038/s41397-019-0098-9. [Epub ahead of print] Review.

PMID:
31624331
2.

Hemodynamic Optimization in Cardiac Resynchronization Therapy: Should We Aim for dP/dtmax or Stroke Work?

Zweerink A, Salden OAE, van Everdingen WM, de Roest GJ, van de Ven PM, Cramer MJ, Doevendans PA, van Rossum AC, Vernooy K, Prinzen FW, Meine M, Allaart CP.

JACC Clin Electrophysiol. 2019 Sep;5(9):1013-1025. doi: 10.1016/j.jacep.2019.05.020. Epub 2019 Jul 31.

PMID:
31537329
3.

1-Year Outcomes of Delayed Versus Immediate Intervention in Patients With Transient ST-Segment Elevation Myocardial Infarction.

Janssens GN, van der Hoeven NW, Lemkes JS, Everaars H, van de Ven PM, Marques KMJ, Nap A, van Leeuwen MAH, Appelman Y, Knaapen P, Verouden NJW, Allaart CP, Brinckman SL, Saraber CE, Plomp KJ, Timmer JR, Kedhi E, Hermanides RS, Meuwissen M, Schaap J, van der Weerdt AP, van Rossum AC, Nijveldt R, van Royen N.

JACC Cardiovasc Interv. 2019 Aug 27. pii: S1936-8798(19)31533-X. doi: 10.1016/j.jcin.2019.07.018. [Epub ahead of print]

PMID:
31488353
4.

No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis.

Hissink Muller PCE, van Braak WG, Schreurs D, Nusman CM, Bergstra SA, Hemke R, Schonenberg-Meinema D, van den Berg JM, Kuijpers TW, Koopman-Keemink Y, van Rossum MAJ, van Suijlekom-Smit LWA, Brinkman DMC, Allaart CF, Ten Cate R, Maas M.

Pediatr Rheumatol Online J. 2019 Sep 4;17(1):62. doi: 10.1186/s12969-019-0362-1.

5.

Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry.

Bergstra SA, Couto MC, Govind N, Chopra A, Salomon Escoto K, Murphy E, Huizinga TW, Allaart CF.

RMD Open. 2019 Jul 30;5(2):e000969. doi: 10.1136/rmdopen-2019-000969. eCollection 2019.

6.

The Benefit of Prophylactic Implantable Cardioverter Defibrillator Implantation in Asymptomatic Heart Failure Patients With a Reduced Ejection Fraction.

van der Lingen ACJ, Timmer SAJ, Allaart LJH, Rijnierse MT, van de Ven PM, van Rossum AC, Kemme MJB, van Halm VP, Allaart CP.

Am J Cardiol. 2019 Aug 15;124(4):560-566. doi: 10.1016/j.amjcard.2019.05.026. Epub 2019 May 29.

7.
8.

Left atrial appendage morphology in atrial fibrillation: Do we prefer chicken wing or cauliflower?

Mulder MJ, Götte MJW, Allaart CP.

J Cardiovasc Comput Tomogr. 2019 Apr 17. pii: S1934-5925(19)30166-2. doi: 10.1016/j.jcct.2019.04.002. [Epub ahead of print] No abstract available.

PMID:
31014929
9.

Correction to: A mobile one-lead ECG device incorporated in a symptom-driven remote arrhythmia monitoring program. The first 5,982 Hartwacht ECGs.

Selder JL, Breukel L, Blok S, van Rossum AC, Tulevski II, Allaart CP.

Neth Heart J. 2019 Mar;27(3):165. doi: 10.1007/s12471-019-1225-6.

10.

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response.

de Moel EC, Derksen VFAM, Trouw LA, Bang H, Collée G, Lard LR, Ramiro S, Huizinga TWJ, Allaart CF, Toes REM, van der Woude D.

Arthritis Res Ther. 2019 Jan 18;21(1):28. doi: 10.1186/s13075-019-1815-0.

11.

Validation of a clinical pharmacogenetic model to predict methotrexate nonresponse in rheumatoid arthritis patients.

Eektimmerman F, Allaart CF, Hazes JM, den Broeder AA, Fransen J, Swen JJ, Guchelaar HJ.

Pharmacogenomics. 2019 Jan;20(2):85-93. doi: 10.2217/pgs-2018-0144. Epub 2019 Jan 10.

PMID:
30628539
12.

Response to: 'Catching the falling star: points to consider when using propensity scores' by Ouyang et al.

Bergstra SA, Allaart CF, Landewé RBM.

Ann Rheum Dis. 2018 Dec 30. pii: annrheumdis-2018-214892. doi: 10.1136/annrheumdis-2018-214892. [Epub ahead of print] No abstract available.

PMID:
30598466
13.

Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?

Hissink Muller PCE, Yildiz B, Allaart CF, Brinkman DMC, van Rossum M, van Suijlekom-Smit LWA, van den Berg JM, Ten Cate R, de Vries MC.

BMC Med Ethics. 2018 Dec 20;19(1):96. doi: 10.1186/s12910-018-0336-8.

14.

An irregular narrow complex tachycardia: atrial fibrillation or something else?

Mulder MJ, Allaart CP, Hauer HA, Kemme MJB.

Neth Heart J. 2019 Feb;27(2):112-113. doi: 10.1007/s12471-018-1217-y. No abstract available.

15.

An irregular narrow complex tachycardia: atrial fibrillation or something else?

Mulder MJ, Allaart CP, Hauer HA, Kemme MJB.

Neth Heart J. 2019 Feb;27(2):108-109. doi: 10.1007/s12471-018-1216-z. No abstract available.

16.

Size Matters: Normalization of QRS Duration to Left Ventricular Dimension Improves Prediction of Long-Term Cardiac Resynchronization Therapy Outcome.

Zweerink A, Friedman DJ, Klem I, van de Ven PM, Vink C, Biesbroek PS, Hansen SM, Emerek K, Kim RJ, van Rossum AC, Atwater BD, Nijveldt R, Allaart CP.

Circ Arrhythm Electrophysiol. 2018 Dec;11(12):e006767. doi: 10.1161/CIRCEP.118.006767.

PMID:
30541355
17.

A mobile one-lead ECG device incorporated in a symptom-driven remote arrhythmia monitoring program. The first 5,982 Hartwacht ECGs.

Selder JL, Breukel L, Blok S, van Rossum AC, Tulevski II, Allaart CP.

Neth Heart J. 2019 Jan;27(1):38-45. doi: 10.1007/s12471-018-1203-4. Erratum in: Neth Heart J. 2019 Mar;27(3):165.

18.

Response to: 'Metering the METEOR in methotrexate failure: is propensity score a falling star?' by Ahmed et al.

Bergstra SA, Allaart CF, Landewé RBM.

Ann Rheum Dis. 2018 Nov 14. pii: annrheumdis-2018-214652. doi: 10.1136/annrheumdis-2018-214652. [Epub ahead of print] No abstract available.

PMID:
30429121
19.

Imaging for cardiac resynchronisation therapy requires cardiac magnetic resonance.

Bhagirath P, Zweerink A, Allaart C, Götte M.

Neth Heart J. 2018 Dec;26(12):640. doi: 10.1007/s12471-018-1195-0. No abstract available.

20.

Magnetic resonance imaging in patients with cardiac implantable electronic devices.

Maass AH, Hemels MEW, Allaart CP.

Neth Heart J. 2018 Dec;26(12):584-590. doi: 10.1007/s12471-018-1192-3. Review.

21.

Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.

Lemkes JS, Janssens GN, van der Hoeven NW, van de Ven PM, Marques KMJ, Nap A, van Leeuwen MAH, Appelman YEA, Knaapen P, Verouden NJW, Allaart CP, Brinckman SL, Saraber CE, Plomp KJ, Timmer JR, Kedhi E, Hermanides RS, Meuwissen M, Schaap J, van der Weerdt AP, van Rossum AC, Nijveldt R, van Royen N.

Eur Heart J. 2019 Jan 14;40(3):283-291. doi: 10.1093/eurheartj/ehy651.

PMID:
30371767
22.

Silent atrial fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease (INDICO AF) trial: study rationale and design.

Baalman SWE, Boersma LVA, Allaart CP, Meine M, Scheerder COS, de Groot JR.

Neth Heart J. 2018 Dec;26(12):628-633. doi: 10.1007/s12471-018-1185-2.

23.

Chronotropic Incompetence in Chronic Heart Failure.

Zweerink A, van der Lingen ACJ, Handoko ML, van Rossum AC, Allaart CP.

Circ Heart Fail. 2018 Aug;11(8):e004969. doi: 10.1161/CIRCHEARTFAILURE.118.004969. Review.

PMID:
30354566
24.

How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studies.

Bergstra SA, Winchow LL, Murphy E, Chopra A, Salomon-Escoto K, Fonseca JE, Allaart CF, Landewé RBM.

Ann Rheum Dis. 2019 Jan;78(1):25-30. doi: 10.1136/annrheumdis-2018-213731. Epub 2018 Oct 16.

PMID:
30327328
25.

Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial.

Hissink Muller P, Brinkman DMC, Schonenberg-Meinema D, van den Bosch WB, Koopman-Keemink Y, Brederije ICJ, Bekkering PW, Kuijpers TW, Van Rossum M, van Suijlekom-Smit LWA, van den Berg JM, Boehringer S, Allaart CF, Ten Cate R.

Ann Rheum Dis. 2019 Jan;78(1):51-59. doi: 10.1136/annrheumdis-2018-213902. Epub 2018 Oct 11.

PMID:
30309970
26.

Atrioventricular optimization in cardiac resynchronization therapy with quadripolar leads: should we optimize every pacing configuration including multi-point pacing?

van Everdingen WM, Zweerink A, Salden OAE, Cramer MJ, Doevendans PA, van Rossum AC, Prinzen FW, Vernooy K, Allaart CP, Meine M.

Europace. 2019 Jan 1;21(1):e11-e19. doi: 10.1093/europace/euy138.

PMID:
30052906
27.

Strain imaging to predict response to cardiac resynchronization therapy: a systematic comparison of strain parameters using multiple imaging techniques.

Zweerink A, van Everdingen WM, Nijveldt R, Salden OAE, Meine M, Maass AH, Vernooy K, de Lange FJ, Vos MA, Croisille P, Clarysse P, Geelhoed B, Rienstra M, van Gelder IC, van Rossum AC, Cramer MJ, Allaart CP.

ESC Heart Fail. 2018 Dec;5(6):1130-1140. doi: 10.1002/ehf2.12335. Epub 2018 Jul 26.

28.

In RA, becoming seronegative over the first year of treatment does not translate to better chances of drug-free remission.

de Moel EC, Derksen VFAM, Trouw LA, Bang H, Goekoop-Ruiterman YPM, Steup-Beekman GM, Huizinga TWJ, Allaart CF, Toes REM, van der Woude D.

Ann Rheum Dis. 2018 Dec;77(12):1836-1838. doi: 10.1136/annrheumdis-2018-213823. Epub 2018 Jul 25. No abstract available.

PMID:
30045852
29.

[MRI in patients with a pacemaker or ICD requires expertise].

Götte MJW, Allaart CP.

Ned Tijdschr Geneeskd. 2018 Jun 18;162. pii: D2910. Dutch.

PMID:
30040331
30.

Pressure-Volume Loop Analysis of Multipoint Pacing With a Quadripolar Left Ventricular Lead in Cardiac Resynchronization Therapy.

van Everdingen WM, Zweerink A, Salden OAE, Cramer MJ, Doevendans PA, Engels EB, van Rossum AC, Prinzen FW, Vernooy K, Allaart CP, Meine M.

JACC Clin Electrophysiol. 2018 Jul;4(7):881-889. doi: 10.1016/j.jacep.2018.02.005. Epub 2018 Mar 28.

31.

Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registry.

Bergstra SA, Branco JC, Vega-Morales D, Salomon-Escoto K, Govind N, Allaart CF, Landewé RBM.

Ann Rheum Dis. 2018 Oct;77(10):1413-1420. doi: 10.1136/annrheumdis-2018-213289. Epub 2018 Jul 6.

PMID:
29980576
32.

Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register.

Bergstra SA, Allaart CF, Ramiro S, Chopra A, Govind N, Silva C, Murphy EA, Landewé RBM.

J Rheumatol. 2018 Oct;45(10):1361-1366. doi: 10.3899/jrheum.171176. Epub 2018 Jun 15.

PMID:
29907672
33.

Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead?

van Everdingen WM, Zweerink A, Cramer MJ, Doevendans PA, Nguyên UC, van Rossum AC, Prinzen FW, Vernooy K, Allaart CP, Meine M.

Circ Arrhythm Electrophysiol. 2018 Mar;11(3):e005912. doi: 10.1161/CIRCEP.117.005912.

PMID:
29874169
34.

Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis.

Akdemir G, Markusse IM, Bergstra SA, Goekoop RJ, Molenaar ET, van Groenendael JHLM, Kerstens PJSM, Lems WF, Huizinga TWJ, Allaart CF.

RMD Open. 2018 May 20;4(1):e000649. doi: 10.1136/rmdopen-2018-000649. eCollection 2018.

35.

SLC04A1, SLC22A2 and SLC28A2 variants not related to methotrexate efficacy or toxicity in rheumatoid arthritis patients.

Eektimmerman F, Swen JJ, Böhringer S, Aslibekyan S, Allaart CF, Guchelaar HJ.

Pharmacogenomics. 2018 May;19(7):613-619. doi: 10.2217/pgs-2018-0021. Epub 2018 Apr 27.

PMID:
29701127
36.

Long-Term Prognostic Implications of Previous Silent Myocardial Infarction in Patients Presenting With Acute Myocardial Infarction.

Amier RP, Smulders MW, van der Flier WM, Bekkers SCAM, Zweerink A, Allaart CP, Demirkiran A, Roos ST, Teunissen PFA, Appelman Y, van Royen N, Kim RJ, van Rossum AC, Nijveldt R.

JACC Cardiovasc Imaging. 2018 Dec;11(12):1773-1781. doi: 10.1016/j.jcmg.2018.02.009. Epub 2018 Apr 18.

37.

The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis.

Becker MAJ, Cornel JH, van de Ven PM, van Rossum AC, Allaart CP, Germans T.

JACC Cardiovasc Imaging. 2018 Sep;11(9):1274-1284. doi: 10.1016/j.jcmg.2018.03.006. Epub 2018 Apr 18.

38.

Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations.

Canhão H, Rodrigues AM, Gregório MJ, Dias SS, Melo Gomes JA, Santos MJ, Faustino A, Costa JA, Allaart C, Gvozdenović E, van der Heijde D, Machado P, Branco JC, Fonseca JE, Silva JA.

Front Med (Lausanne). 2018 Mar 8;5:40. doi: 10.3389/fmed.2018.00040. eCollection 2018.

39.

Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes.

de Moel EC, Derksen VFAM, Stoeken G, Trouw LA, Bang H, Goekoop RJ, Speyer I, Huizinga TWJ, Allaart CF, Toes REM, van der Woude D.

Arthritis Res Ther. 2018 Feb 26;20(1):33. doi: 10.1186/s13075-018-1520-4.

40.

TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.

Loef M, Kroon FPB, Bergstra SA, van der Pol JA, Lems WF, Kerstens PJSM, Allaart CF, Kloppenburg M.

Rheumatology (Oxford). 2018 Nov 1;57(11):1917-1924. doi: 10.1093/rheumatology/key016.

PMID:
29471377
41.

What is the optimal target for treat-to-target strategies in rheumatoid arthritis?

Bergstra SA, Allaart CF.

Curr Opin Rheumatol. 2018 May;30(3):282-287. doi: 10.1097/BOR.0000000000000484.

PMID:
29356697
42.

Don't judge the myocardium by its cover : The incremental value of cardiac magnetic resonance imaging in left ventricular hypertrophy.

Parbhudayal RY, Allaart CP, van Loon RB, Meijboom LJ, van Rossum AC, Nijveldt R.

Neth Heart J. 2018 Mar;26(3):167-168. doi: 10.1007/s12471-017-1069-x. No abstract available.

43.

Accuracy of oscillometric blood pressure measurement in atrial fibrillation.

Feenstra RK, Allaart CP, Berkelmans GFN, Westerhof BE, Smulders YM.

Blood Press Monit. 2018 Apr;23(2):59-63. doi: 10.1097/MBP.0000000000000305.

PMID:
29256921
44.

Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis.

Bergstra SA, Allaart CF, van den Berg R, Chopra A, Govind N, Huizinga TWJ, Landewe RBM.

Arthritis Res Ther. 2017 Nov 22;19(1):258. doi: 10.1186/s13075-017-1468-9.

45.

Comparison of strain parameters in dyssynchronous heart failure between speckle tracking echocardiography vendor systems.

van Everdingen WM, Maass AH, Vernooy K, Meine M, Allaart CP, De Lange FJ, Teske AJ, Geelhoed B, Rienstra M, Van Gelder IC, Vos MA, Cramer MJ.

Cardiovasc Ultrasound. 2017 Oct 18;15(1):25. doi: 10.1186/s12947-017-0116-5.

46.

Comparison of strain imaging techniques in CRT candidates: CMR tagging, CMR feature tracking and speckle tracking echocardiography.

van Everdingen WM, Zweerink A, Nijveldt R, Salden OAE, Meine M, Maass AH, Vernooy K, De Lange FJ, van Rossum AC, Croisille P, Clarysse P, Geelhoed B, Rienstra M, Van Gelder IC, Vos MA, Allaart CP, Cramer MJ.

Int J Cardiovasc Imaging. 2018 Mar;34(3):443-456. doi: 10.1007/s10554-017-1253-5. Epub 2017 Oct 17.

47.

Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study.

Akdemir G, Heimans L, Bergstra SA, Goekoop RJ, van Oosterhout M, van Groenendael JHLM, Peeters AJ, Steup-Beekman GM, Lard LR, de Sonnaville PBJ, Grillet BAM, Huizinga TWJ, Allaart CF.

Ann Rheum Dis. 2018 Jan;77(1):111-118. doi: 10.1136/annrheumdis-2017-211375. Epub 2017 Sep 28.

PMID:
28970207
48.

Further Treatment Intensification in Undifferentiated and Rheumatoid Arthritis Patients Already in Low Disease Activity has Limited Benefit towards Physical Functioning.

Bergstra SA, Olivas O, Akdemir G, Riyazi N, Collée G, van Groenendael JHLM, Landewé RBM, Allaart CF.

Arthritis Res Ther. 2017 Sep 30;19(1):220. doi: 10.1186/s13075-017-1425-7.

49.

Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapy.

Bergstra SA, Landewé RBM, Huizinga TWJ, Allaart CF.

Rheumatology (Oxford). 2017 Oct 1;56(10):1721-1728. doi: 10.1093/rheumatology/kex236.

PMID:
28957556
50.

What have we learned from BeSt?

Allaart CF, Markusse IM, Lems WF.

Clin Immunol. 2018 Jan;186:74-78. doi: 10.1016/j.clim.2017.09.017. Epub 2017 Sep 18.

Supplemental Content

Loading ...
Support Center